Export Compliance Daily is a service of Warren Communications News.

CBP Finds Country of Origin of Herpes Medicine is China and India for Government Procurement

Tablets containing Acyclovir, a pharmaceutical product active against herpes viruses, are produced in China and India, said CBP in a final determination published Nov. 13 (here). The Acyclovir is manufactured in China and India and goes through additional manufacturing in the U.S, said CBP. "The Acyclovir retains its chemical and physical properties and is merely put into a dosage form and is packaged for sale" while in the U.S, said CBP. As a result, "no substantial transformation occurs in U.S., and for purposes of government procurement, the Acyclovir tablets would be considered a product where the active ingredient was produced, which would be China and India," it said.

Sign up for a free preview to unlock the rest of this article

Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.

(Federal Register 11/13/15)